title: [Drug costs should be based on health economic benefits. A new law on drug benefits requires studies of health economic effects].
authors.affiliation: Universitetssjukhuset MAS, avdelningen för hälsoekonomi, Lunds universitet, Centrum för hälsoekonomi (LUCHE). fredrik.berggren@luche.lu.se
authors.forename: Fredrik
authors.initials: F
authors.lastname: Berggren
mesh_terms: D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D017048:Health Care Costs / Q000331:legislation & jurisprudence*; D005102:Health Expenditures / Q000331:legislation & jurisprudence*; D006801:Humans; D007348:Insurance, Health / Q000331:legislation & jurisprudence*; D018803:Models, Economic; D019057:Quality-Adjusted Life Years; D013548:Sweden